Home
NewsNewsThe AI-specialized Infertility Center, which is the largest in Asia, is open in Magok, Seoul and has begun its full-scale medical services from November 17 thereby marking the new era when it comes to fertility in the region.
CHA Hospital, which is a medical institution that specializes in infertility treatment, has gone on to open the first artificial intelligence: AI-specialized infertility center in the Magok district of Seoul.
On November 12, CHA Hospital announced that Magok CHA Hospital, which happens to feature the largest scale of 6,611 square meters along with 5 operating rooms, 9 consultation rooms, an AI egg bank, and clean room culture facilities that meet the international benchmarks, will start its full-scale medical services on November 17, 2025.
It is well to be noted that CHA Hospital, with its AI-specialized Infertility Center, looks to execute a future-oriented infertility treatment model, which happens to be based on precision medicine through combining the massive reproductive medicine data that’s accumulated by CHA Hospital Group in the last 65 years due to AI technology and, of course, the patient-centered treatment philosophy. CHA Hospital's general director and leading authority on domestic infertility treatment, Han Se-yeol, is joined by the former Seoul National University professor who delivered Korea's first test-tube baby, Moon Shin-yong.
Moon Shin-yong has joined as the honorary director. The well-versed medical staff includes the likes of Yeom Seon-hyeong and Profs. Yang Nu-ri and Lim Jeong-mi, as well as Kim Ji-eun from the Seoul Station Center, and also Prof. Jeong Ja-yeon, who happens to be from Bundang CHA Hospital all of whom have joined to plan tailor-made treatment for patients who are experiencing difficulties when it comes to pregnancy. Being an industry first, the hospital has gone in to recruit AI specialists and is also going to showcase precision infertility treatment by way of advanced systems, including AI embryo grading classification, reproductive cell - sperm/egg AI automatic analysis, implantation possibility prediction, and also PGT -preimplantation genetic testing auxiliary analysis.
AI technology is also going to be applied to the egg freezing field so as to accurately predict egg quality and also freezing timing as well as anticipate and analyze the embryo formation probabilities post thawing to support the fertility preservation of women. Infertility researchers having over 20 years of experience are going to work along with medical staff in order to make sure of high rates of pregnancy success. Apparently, the first infertility center-specialized KareChat service in Korea is also going to be introduced. KareChat is indeed a smart healthcare platform that enables convenient usage of hospital appointment booking and infertility-related educational content based on KakaoTalk and also schedule changes without even installing any separate application. By doing this, infertility patients can seamlessly go ahead and check essential information before visiting the hospital and, at the same time, conveniently manage schedules pertaining to personalized infertility treatment.
Given the excellent airport accessibility of the hospital, it looks forward to making Magok the hub when it comes to K-infertility through connecting with the hotels nearby.
The director of Magok CHA Hospital, Han Se-yeol, remarked that in an era where scientific as well as technological advancement along with artificial intelligence go on to lead the medical changes, they are going to offer more scientific and accurate customized treatment services by way of combining cutting-edge technology. He further added that if Jamsil CHA Hospital goes on to open the first in vitro maturation IVM specialized research center in Korea in 2024 so as to present the probability of customized test-tube procedures, Magok CHA Hospital is going to write a completely new paradigm when it comes to complete infertility treatment that is based on AI.
A new Ipsos survey commissioned by Fertility Matters Canada finds 49% of Canadians with an opinion support a national baseline for IVF funding support, with backing rising to 59% among those aged 18–34. One in eight Canadians say cost has already forced them or someone close to delay or abandon fertility treatment.
Alpha Controls & Instrumentation Inc. has been selected by FertiTech Canada Inc. as its third-party calibration partner for Nilotech temperature probes. The partnership channels Canadian IVF laboratories and fertility clinics using Nilotech equipment to Alpha Controls for professional, accredited calibration services, while FertiTech continues to handle equipment supply and gas sensor calibration.
In the UK, a Ten Minute Rule Bill has been introduced in the Commons to create a legal right to paid time off for fertility treatment, aiming to standardize access to time‑sensitive appointments and reduce reliance on employer discretion. The proposal seeks House permission to proceed and spotlights workplace rights during Fertility Awareness Week.
Columbia University Fertility Center has achieved the first confirmed pregnancy using an AI-guided sperm recovery method in a man with azoospermia, as detailed in The Lancet. The STAR system combined advanced imaging, microfluidics, and robotics to retrieve two viable sperm, enabling embryo creation after prior failed surgical and manual attempts.
British Columbia's free IVF program exhausts 2025 funding within months of launch. At least one approved clinic stops accepting new applications. Applicants face aging-out risks and must wait until spring 2026 for next funding allocation.
Singapore’s MOH approves 13 additional genetic conditions for testing before embryos are implanted during IVF, enhancing reproductive genetic screening options.
National Health Service-funded IVF in England varies across regions in terms of access, cycle definitions, and eligibility. While Integrated Care Boards follow NICE guidelines, local implementation differs to meet specific population needs. Current policy reviews aim to enhance consistency and ensure continued access to fertility services across England.
